Aspire Biopharma Holdings, Inc. (ASBP) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Aspire Biopharma Holdings, Inc. on June 17, 2025. The Company is an emerging growth company incorporated in Delaware with its common stock and warrants trading on The Nasdaq Stock Market LLC under the symbols ASBP and ASBPW, respectively.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report does not contain financial statements or performance metrics.
Material Changes
Under Item 8.01 (Other Events), the Board of Directors changed the Company's principal executive office, principal place of business, and headquarters. The new location is 23150 Fashion Drive, Suite 232, Estero, Florida 33928. The former address was 194 Candelaro Drive, #233, Humacao, Puerto Rico 00791.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the address change.
Key Facts for Investor Verification
- Confirm the operational impact of relocating headquarters from Puerto Rico to Florida.
- Verify the effective date of the address change for legal and correspondence purposes.
- Check subsequent filings for any financial implications related to the relocation.